Literature DB >> 29183566

Application of pressure-derived myocardial fractional flow reserve in chronic hemodialysis patients.

Kimihiko Hirose1, Taishiro Chikamori2, Satoshi Hida1, Nobuhiro Tanaka3, Jun Yamashita1, Yuko Igarashi1, Tetsushi Saitoh1, Hirokazu Tanaka4, Akira Yamashina1.   

Abstract

BACKGROUND: Although fractional flow reserve (FFR) measurements during coronary angiography are performed in routine clinical practice, few studies have evaluated FFR measurements in dialysis patients.
METHODS: We retrospectively studied 42 hemodialysis patients with suspected or known coronary artery disease (CAD) who underwent stress myocardial perfusion imaging and coronary angiography with FFR measurements for 61 coronary lesions. The cut-off value for FFR to detect myocardial ischemia was determined by receiver operating characteristic (ROC) curve analysis.
RESULTS: There were 61 coronary vessels measured by FFR. The FFR range was 0.34-0.93 with a mean of 0.74±0.13. The ROC curve analysis revealed that the best cut-off value of FFR for detecting myocardial ischemia was 0.76 (p<0.0001), with 70% sensitivity, 86% specificity, and 76% accuracy for myocardial ischemia. Compared with patients who had positive myocardial ischemia and an FFR≤0.76, those who had negative myocardial ischemia despite an FFR≤0.76 had less left ventricular (LV) mass index, whereas patients who had positive myocardial ischemia despite an FFR>0.76 had greater LV mass indexor serum calcium-phosphorus product.
CONCLUSIONS: The cut-off value of FFR for myocardial ischemia in chronic hemodialysis patients is similar to that in other CAD patients. However, caution is necessary when FFR measurements are applied to dialysis patients with significantly increased LV mass index or serum calcium-phosphorus product.
Copyright © 2017 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic; Coronary artery disease; Fractional flow reserve; Imaging; Myocardial perfusion; Renal disease

Mesh:

Year:  2018        PMID: 29183566     DOI: 10.1016/j.jjcc.2017.05.007

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  5 in total

1.  On-site evaluation of CT-based fractional flow reserve using simple boundary conditions for computational fluid dynamics.

Authors:  Yusuke Yoshikawa; Masahiko Nakamoto; Masanori Nakamura; Takeharu Hoshi; Erika Yamamoto; Shunsuke Imai; Yoshiaki Kawase; Munenori Okubo; Hiroki Shiomi; Takeshi Kondo; Hitoshi Matsuo; Takeshi Kimura; Naritatsu Saito
Journal:  Int J Cardiovasc Imaging       Date:  2019-10-18       Impact factor: 2.357

2.  Fractional Flow Reserve Versus Instantaneous Wave-Free Ratio in Assessment of Lesion Hemodynamic Significance and Explanation of their Discrepancies. International, Multicenter and Prospective Trial: The FiGARO Study.

Authors:  Tomas Kovarnik; Matsuo Hitoshi; Ales Kral; Stepan Jerabek; David Zemanek; Yoshiaki Kawase; Hiroyuki Omori; Toru Tanigaki; Jan Pudil; Alexandra Vodzinska; Marian Branny; Roman Stipal; Petr Kala; Jan Mrozek; Martin Porzer; Tomas Grezl; Kamil Novobilsky; Oscar Mendiz; Karel Kopriva; Martin Mates; Martin Chval; Zhi Chen; Pavel Martasek; Ales Linhart
Journal:  J Am Heart Assoc       Date:  2022-05-03       Impact factor: 6.106

3.  The assessment of coronary artery disease in patients with end-stage renal disease.

Authors:  Federica E Poli; Gaurav S Gulsin; Gerry P McCann; James O Burton; Matthew P Graham-Brown
Journal:  Clin Kidney J       Date:  2019-08-14

4.  High dose escalation of intracoronary adenosine in the assessment of fractional flow reserve: A retrospective cohort study.

Authors:  Chien-Boon Jong; Tsui-Shan Lu; Patrick Yan-Tyng Liu; Mu-Yang Hsieh; Shih-Wei Meng; Ching-Chang Huang; Hsien-Li Kao; Chih-Cheng Wu
Journal:  PLoS One       Date:  2020-10-15       Impact factor: 3.240

5.  Safety of coronary revascularization deferral based on fractional flow reserve and instantaneous wave-free ratio in patients with chronic kidney disease.

Authors:  Alejandro Travieso; Alex Fernando Castro-Mejia; Adrian Jeronimo-Baza; Maria Jose Perez-Vizcayno; Hernan Mejia-Renteria; Fernando Macaya; Gabriela Tirado-Conte; Luis Nombela; Pilar Jimenez-Quevedo; Pablo Salinas; Ivan J Nunez-Gil; Antonio Fernandez-Ortiz; Javier Escaned; Nieves Gonzalo
Journal:  Cardiol J       Date:  2021-04-12       Impact factor: 3.487

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.